JP2019199476A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019199476A5 JP2019199476A5 JP2019132856A JP2019132856A JP2019199476A5 JP 2019199476 A5 JP2019199476 A5 JP 2019199476A5 JP 2019132856 A JP2019132856 A JP 2019132856A JP 2019132856 A JP2019132856 A JP 2019132856A JP 2019199476 A5 JP2019199476 A5 JP 2019199476A5
- Authority
- JP
- Japan
- Prior art keywords
- agent according
- subject
- engrafted
- hsc
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161477440P | 2011-04-20 | 2011-04-20 | |
| US61/477,440 | 2011-04-20 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017243476A Division JP6560332B2 (ja) | 2011-04-20 | 2017-12-20 | 単一サイクルでコンディショニングおよび化学選択を組み合わせる方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019199476A JP2019199476A (ja) | 2019-11-21 |
| JP2019199476A5 true JP2019199476A5 (enExample) | 2020-04-09 |
| JP6799117B2 JP6799117B2 (ja) | 2020-12-09 |
Family
ID=47041955
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014506605A Expired - Fee Related JP5997257B2 (ja) | 2011-04-20 | 2012-04-20 | 単一サイクルでコンディショニングおよび化学選択を組み合わせる方法 |
| JP2016164295A Expired - Fee Related JP6266716B2 (ja) | 2011-04-20 | 2016-08-25 | 単一サイクルでコンディショニングおよび化学選択を組み合わせる方法 |
| JP2017243476A Expired - Fee Related JP6560332B2 (ja) | 2011-04-20 | 2017-12-20 | 単一サイクルでコンディショニングおよび化学選択を組み合わせる方法 |
| JP2019132856A Expired - Fee Related JP6799117B2 (ja) | 2011-04-20 | 2019-07-18 | 単一サイクルでコンディショニングおよび化学選択を組み合わせる方法 |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014506605A Expired - Fee Related JP5997257B2 (ja) | 2011-04-20 | 2012-04-20 | 単一サイクルでコンディショニングおよび化学選択を組み合わせる方法 |
| JP2016164295A Expired - Fee Related JP6266716B2 (ja) | 2011-04-20 | 2016-08-25 | 単一サイクルでコンディショニングおよび化学選択を組み合わせる方法 |
| JP2017243476A Expired - Fee Related JP6560332B2 (ja) | 2011-04-20 | 2017-12-20 | 単一サイクルでコンディショニングおよび化学選択を組み合わせる方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9439928B2 (enExample) |
| EP (3) | EP3384912B1 (enExample) |
| JP (4) | JP5997257B2 (enExample) |
| AU (3) | AU2012245269B2 (enExample) |
| CA (1) | CA2861440C (enExample) |
| DK (1) | DK2699247T3 (enExample) |
| ES (1) | ES2672693T3 (enExample) |
| PL (1) | PL2699247T3 (enExample) |
| RU (2) | RU2611396C2 (enExample) |
| TR (1) | TR201808037T4 (enExample) |
| WO (1) | WO2012145723A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012145723A1 (en) * | 2011-04-20 | 2012-10-26 | The Regents Of The University Of California | Method for combined conditioning and chemoselection in a single cycle |
| US9682106B2 (en) * | 2011-04-20 | 2017-06-20 | The Regents Of The University Of California | Method for combined conditioning and chemoselection in a single cycle |
| WO2016022166A1 (en) * | 2014-08-07 | 2016-02-11 | Nitor Therapeutics | Use of pnp inhibitor to treat relapse of malignancy after hematopoietic stem cell transplant |
| US20180140606A1 (en) * | 2016-11-18 | 2018-05-24 | Calimmune, Inc. | In Vivo Chemoselection with Low Dose Thioguanine |
| JP6783674B2 (ja) | 2017-01-20 | 2020-11-11 | 株式会社日立ハイテク | 自動分析装置、自動分析装置における廃液方法、及び、三方電磁弁 |
| SG11202000428PA (en) * | 2017-07-18 | 2020-02-27 | Calimmune Inc | A modulatable switch for selection of donor modified cells |
| WO2019018383A1 (en) * | 2017-07-18 | 2019-01-24 | Calimmune, Inc. | COMPOSITIONS AND METHODS FOR TREATING BETA-HEMOGLOBINOPATHIES |
| US12359200B2 (en) | 2017-10-09 | 2025-07-15 | Stowers Institute For Medical Research | Methods and compositions for expansion of cell population |
| CA3123045A1 (en) * | 2018-12-23 | 2020-07-02 | Csl Behring L.L.C. | Donor t-cells with kill switch |
| BR112021012240A2 (pt) * | 2018-12-23 | 2022-01-18 | Csl Behring Llc | Terapia de gene-célula-tronco hematopoiética para síndrome wiskott-aldrich |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965126A (en) | 1996-03-25 | 1999-10-12 | The Penn State Research Foundation | use of mutant alkyltransferases for gene therapy to protect from toxicity of therapeutic alkylating agents |
| WO1997043900A1 (en) * | 1996-05-24 | 1997-11-27 | The President And Fellows Of Harvard College | In vivo selection |
| WO1998019540A1 (en) | 1996-11-04 | 1998-05-14 | Saint Jude Children's Research Hospital | In vivo selection of primitive hematopoietic cells |
| DE69841058D1 (de) * | 1997-11-14 | 2009-09-24 | Gen Hospital Corp | Behandlung von hämatologischen störungen |
| GB9904281D0 (en) * | 1999-02-24 | 1999-04-21 | Reneuron Ltd | Transplantation |
| US7094885B2 (en) * | 1999-07-11 | 2006-08-22 | Neorx Corporation | Skeletal-targeted radiation to treat bone-associated pathologies |
| US20030032003A1 (en) | 2000-02-02 | 2003-02-13 | Schiestl Robert H. | In vivo selection |
| AU2002219828A1 (en) | 2000-11-14 | 2002-05-27 | The General Hospital Corporation | Blockade of T cell migration into epithelial GVHD target tissues |
| US7037900B2 (en) * | 2001-10-12 | 2006-05-02 | Supergen, Inc. | Composition and method for treating graft-versus-host disease |
| WO2012145723A1 (en) * | 2011-04-20 | 2012-10-26 | The Regents Of The University Of California | Method for combined conditioning and chemoselection in a single cycle |
-
2012
- 2012-04-20 WO PCT/US2012/034586 patent/WO2012145723A1/en not_active Ceased
- 2012-04-20 EP EP18159906.9A patent/EP3384912B1/en not_active Not-in-force
- 2012-04-20 RU RU2013151632A patent/RU2611396C2/ru active
- 2012-04-20 EP EP12774246.8A patent/EP2699247B1/en active Active
- 2012-04-20 DK DK12774246.8T patent/DK2699247T3/en active
- 2012-04-20 AU AU2012245269A patent/AU2012245269B2/en not_active Ceased
- 2012-04-20 CA CA2861440A patent/CA2861440C/en active Active
- 2012-04-20 ES ES12774246.8T patent/ES2672693T3/es active Active
- 2012-04-20 PL PL12774246T patent/PL2699247T3/pl unknown
- 2012-04-20 RU RU2017104621A patent/RU2728867C2/ru active
- 2012-04-20 JP JP2014506605A patent/JP5997257B2/ja not_active Expired - Fee Related
- 2012-04-20 TR TR2018/08037T patent/TR201808037T4/tr unknown
- 2012-04-20 EP EP20190457.0A patent/EP3799876A1/en not_active Withdrawn
- 2012-04-20 US US14/112,878 patent/US9439928B2/en not_active Expired - Fee Related
-
2016
- 2016-08-25 JP JP2016164295A patent/JP6266716B2/ja not_active Expired - Fee Related
- 2016-11-17 AU AU2016259368A patent/AU2016259368B2/en not_active Ceased
-
2017
- 2017-12-20 JP JP2017243476A patent/JP6560332B2/ja not_active Expired - Fee Related
-
2018
- 2018-02-09 AU AU2018200967A patent/AU2018200967B2/en not_active Ceased
-
2019
- 2019-07-18 JP JP2019132856A patent/JP6799117B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019199476A5 (enExample) | ||
| JP7216829B2 (ja) | Ｘｅｌｏｘ又はｆｏｌｆｏｘと組み合わせたｔｔフィールドを用いる胃癌の治療 | |
| ES2653615T3 (es) | Pluralidad de dosis de LAG-3 recombinante para su uso en la provocación de una respuesta inmunitaria de monocitos | |
| Essers et al. | Targeting leukemic stem cells by breaking their dormancy | |
| US10842763B2 (en) | Methods for cancer and immunotherapy using prodrugs of glutamine analogs | |
| JP2014512391A5 (enExample) | ||
| US20130209578A1 (en) | Combinatory Cancer Treatment | |
| JP2020528455A5 (enExample) | ||
| CN109152839A (zh) | 双极性反式类胡萝卜素连同化疗和放射治疗在治疗癌症中的用途 | |
| KR20180041229A (ko) | 줄기 세포 이식을 위한 방법 | |
| Parsonidis et al. | Adoptive cellular transfer immunotherapies for cancer | |
| Horwitz et al. | Myeloablative intravenous busulfan/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients | |
| RU2010145048A (ru) | On01910.na, усиливающий активность химиотерапевтического агента в резистентных к лекарственным средствам опухолях | |
| Lee et al. | Pralatrexate in combination with bortezomib for relapsed or refractory peripheral T cell lymphoma in 5 elderly patients | |
| Pak | Alpha-Fetoprotein: A revolutionary anti-cancer drug | |
| CN118903175A (zh) | 小分子药物联用在增强低氧条件下nk细胞的代谢、杀伤能力中的应用 | |
| CN110327362A (zh) | 次黄嘌呤核苷酸在制备抗抑郁药物中的应用 | |
| CN106928298A (zh) | 环二核苷酸cGAMP衍生物的结构组成、制备方法及其在抗肿瘤中的应用 | |
| MD3803G2 (ro) | Metodă de tratament al hiperchineziilor la copii | |
| CN107281177B (zh) | 促进造血干细胞归巢和植入的方法 | |
| JP2017530142A (ja) | 急性骨髄性白血病及び骨髄異形成症候群の併用療法ｉｉｉ | |
| Srikanth et al. | Enhanced regression of tumors in mice with combined chemotherapy and immunotherapy | |
| Madabushi et al. | Targeted marrow radiation (TMI) improves therapeutic efficacy of Stat3 decoy molecules by augmenting its delivery and immune modulation in an aml mouse model | |
| Krasowska et al. | Mantle Cell Lymphoma: Effectiveness of Maintenance Ibrutinib–Case Report | |
| Lázár et al. | Difficulties of Mobilization and Harvesting of Hematopoietic Stem Cells in Heavily Pre-Treated Patients |